Law360, New York (October 11, 2012, 3:41 PM ET) -- GlaxoSmithKline PLC announced Thursday it would make data from clinical trials for its approved drugs and abandoned treatments available to the public, a move it classified as the first of its kind in the drug industry.
Researchers will be able to submit requests to an independent panel of experts established by GSK for anonymized, patient-level data, the drugmaker said. The system will include data from clinical trials that begin in January 2013 or later, as well as data from global trials conducted since 2007, according to...
GSK To Make Trial Data Available To Researchers
To view the full article, take a free trial now.
